Nitric oxide from mononuclear cells may be involved in platelet responsiveness to aspirin

European Journal of Clinical Investigation

Volumn 44, Issue 5, 2014, Pages 463-469

  López Farré, Antonio J ^a   Modrego, Javier ^a   Azcona, Luis ^a   Guerra, Reddy ^a   Segura, Antonio ^b   Rodríguez, Pablo ^a   Zamorano León, José J ^a   Lahera, Vicente ^c   MacAya, Carlos ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Health Science Institute from Talavera de la Reina ^*  (Spain)

^c SCHOOL OF MEDICINE   (Spain)

Author keywords

Aspirin; Mononuclear cells; Nitric oxide; Platelets; Vitamin D binding protein

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; VITAMIN D BINDING PROTEIN; ANTITHROMBOCYTIC AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; THROMBOCYTE; BIOSYNTHESIS; DRUG RESISTANCE; METABOLISM;

AGED; ASPIRIN; BLOOD PLATELETS; CORONARY ARTERY DISEASE; DRUG RESISTANCE; FEMALE; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLATELET AGGREGATION INHIBITORS; VITAMIN D-BINDING PROTEIN;

EID: 84908392673     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12252     Document Type: Article

References (25)

1. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006;367:606-17.
2. de Gaetano G, Cerletti C, Dejana E, Latini R. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation 1985;72:1185-93.
3. López-Farré A, Caramelo C, Esteban A, Alberola ML, Millás I, Montón M et al. Effects of aspirin on platelet-neutrophil interactions: role of nitric oxide and endothelin-1. Circulation 1995;91:2080-8.
4. García-Cardoso J, Vela R, Mahillo E, Mateos-Cáceres PJ, Modrego J, Macaya C et al. Increased cyclic guanosine monophosphate production and endothelial nitric oxide synthase level in mononuclear cells from sildenafil citrate-treated patients with erectile dysfunction. Int J Impot Res 2010;22:68-76.
5. Taubert D, Berkels R, Grosser N, Schröder H, Gründemann D, Schömig E. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol 2004;143:159-65.
6. Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 2003;1:1710-3.
7. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. Br Med J 2008;336:195-8.
8. Reny JL, De Moerloose P, Dauzat M, Fontana P. Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 2008;99:14-26.
9. Macchi L, Sorel N, Christiaens L. Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance. Curr Pharm Des 2006;12:251-8.
10. Mateos-Cáceres PJ, Macaya C, Azcona L, Modrego J, Mahillo E, Bernardo E et al. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb Haemost 2009;103:160-70.
11. López-Farré AJ, Mateos-Cáceres PJ, Sacristán D, Azcona L, Bernardo E, de Prada TP et al. Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res 2007;6:2481-7.
12. Kew RR, Sibug MA, Liuzzo JP, Webster RO. Localization and quantitation of the vitamin D binding protein (Gc-globulin) in human neutrophils. Blood 1993;82:274-83.
13. Constans J, Oksman F, Viau M. Binding of the apo and holo forms of the serum vitamin D-binding protein to human lymphocyte cytoplasm and membrane by indirect immunofluorescence. Immunol Lett 1981;3:159-62.
14. López-Farré AJ, Zamorano-León JJ, Segura A, Mateos-Cáceres PJ, Modrego J, Rodríguez-Sierra P et al. Plasma desmoplakin I: biomarker of vascular recurrence after ischemic stroke. J Neurochem 2012;121:314-25.
15. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
16. Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK et al. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 2006;6:68.
17. Guoth M, Murgia A, Smith RM, Prystowsky MB, Cooke NE, Haddad JG. Cell surface vitamin D-binding protein (GC-globulin) is acquired from plasma. Endocrinology 1990;127:2313-21.
18. Gori AM, Cesari F, Marcucci R, Giusti B, Paniccia R, Antonucci E et al. The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Atherosclerosis 2009;202:255-62.
19. García-Zubiri C, Citores MJ, Yebra-Bango M. Contribution of monocytes to overproduction of interleukin-6 in a case of cardiac myxoma. Am J Med Sci 2009;338:336-7.
20. St Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 1996;184:1173-8.
21. Ziegler S, Alt E, Brunner M, Speiser W, Minar E. Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients. Ann Hematol 2004;83:92-4.
22. Trujillo G, Kew RR. Platelet-derived thrombospondin-1 is necessary for the vitamin D-binding protein (Gc-globulin) to function as a chemotactic cofactor for C5a. J Immunol 2004;173:4130-6.
23. Faraday N, Scharpf RB, Dodd-o JM, Martinez EA, Rosenfeld BA, Dorman T. Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of p-selectin glycoprotein ligand-1 with P-selectin. Anesthesiology 2001;94:145-51.
24. Cardaropoli S, Silvagno F, Morra E, Pescarmona GP, Todros T. Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro. J Hypertens 2003;21:2103-10.
25. Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Alfieri AB, Cubeddu LX. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005;19:233-40.